Literature DB >> 18937791

Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis.

J Wongpiyabovorn1, S Yooyongsatit, K Ruchusatsawat, Y Avihingsanon, N Hirankarn.   

Abstract

Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis. Three single nucleotide polymorphisms (SNPs) within the promoter and exon 1 region [-2578(C/A), -460(C/T) and +405(C/G)] were analyzed in 154 patients with chronic plaque psoriasis and in 234 ethnically matched healthy controls from Thailand. The CTG (-2578/-460/+405) haplotype frequency was higher in patients with early-onset psoriasis (44.12%) compared with healthy controls (33.33%) (odds ratio = 1.54, 95% confidence interval = 1.08-2.18, P = 0.016, corrected P value: P(c) = 0.048). The results suggest that the CTG haplotype can be used as a genetic marker for psoriasis especially the early-onset group of Thais.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937791     DOI: 10.1111/j.1399-0039.2008.01134.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

Review 1.  The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis.

Authors:  Caitriona Ryan; Alan Menter; Richard B Warren
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

2.  Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis.

Authors:  Ni Wei; Zijia Chen; Zhifeng Xue; Yuelan Zhu
Journal:  Rheumatol Int       Date:  2015-05-26       Impact factor: 2.631

3.  Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: a meta-analysis.

Authors:  Min Qi; Xiaoyuan Huang; Lei Zhou; Jianglin Zhang
Journal:  DNA Cell Biol       Date:  2014-04       Impact factor: 3.311

Review 4.  The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Authors:  Marina Talamonti; Simone D'Adamio; Luca Bianchi; Marco Galluzzo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

5.  Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.

Authors:  Xia Chen; Qiong-Yi Hu; Mengyan Wang; Jinchao Jia; Jialin Teng; Yue Sun; Xiaobing Cheng; Junna Ye; Yutong Su; Hui Shi; Huihui Chi; Zhuochao Zhou; Tingting Liu; Zhihong Wang; Liyan Wan; Xin Qiao; Fan Wang; Xinyao Wu; Chengde Yang; Hong-Lei Liu
Journal:  Rheumatol Int       Date:  2021-09-09       Impact factor: 2.631

6.  Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene.

Authors:  Tuba Bozduman; Sibel Ersoy Evans; Sevilay Karahan; Yildiz Hayran; Filiz Akbiyik; Incilay Lay
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.